Purpose: This study investigated the perioperative risk factors of postoperative pulmonary complications (PPCs) after minimally invasive anatomic resection for lung cancer.
Introduction
Lung cancer is the leading cause of cancer death worldwide for both genders, and anatomic lung resection is widely considered the optimal therapy for early-stage lung cancer. 1 Video-assisted thoracoscopic surgery or robotic-assisted thoracoscopic surgery is being increasingly performed for early-stage lung cancer instead of open thoracotomy because of its minimally invasive nature. 2 Despite the improvement in surgical techniques, postoperative pulmonary complications (PPCs) still occur in 12%-40% of patients after surgical lung resection, and increase hospital mortality, postoperative length of stay (PLOS), and total hospital care costs. 1 Several previous studies have suggested that the patient's age, gender, and body mass index (BMI), as well as smoking and COPD, are risk factors of PPCs after lung resection. [3] [4] [5] However, data regarding the risk factors of PPCs after lung resection are still limited and often from small sample sizes. [3] [4] [5] [6] Moreover, there are too many perioperative associated submit your manuscript | www.dovepress.com
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Yang et al factors for PPCs after lung resection, many of which are still are not being studied and understood. Therefore, further research is needed to address this knowledge gap. In this study, we retrospectively reviewed patients with lung cancer undergoing minimally invasive anatomic resection and compared the perioperative factors between patients with PPCs and patients with no PPCs. The study aimed to identify perioperative risk factors for the development of PPCs after minimally invasive anatomic resection for lung cancer. Knowledge about these factors might help to identify patients at elevated risk for the development of PPCs and, therefore, contribute to a decrease in such complications.
Patients and methods
The Medical Ethics Committee of the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China, approved the study. Because the data were recorded retrospectively and without any specific intervention, the Medical Ethics Committee agreed to waive the need for informed consent. Data were deidentified to protect the privacy and maintain confidentiality of patient information. It was conducted in accordance with the 1964 Declaration of Helsinki and its later amendments covering patient data confidentiality.
study population
We retrospectively collected the records of consecutive lung cancer patients who had undergone anatomic lung resections between January 2017 and December 2017, at the First Affiliated Hospital, College of Medicine, Zhejiang University. The inclusion criteria were 1) patients aged over 18 years, 2) patients who had undergone minimally invasive anatomic lung resections under general anesthesia with double-lumen intubation, and 3) pathological confirmation of lung cancer. Minimally invasive anatomic lung resection was defined as lobectomy or segmentectomy under video-assisted thoracoscopic surgery or robotic-assisted thoracoscopic surgery. Exclusion criteria were patients who had undergone 1) open surgery and 2) conversion to thoracotomy. A total of 922 patient records were evaluated, but 193 were excluded because of open surgery (n=162), conversion to thoracotomy (n=27), or incomplete data (n=4). Finally, 729 valid cases were included (Figure 1) .
Detailed patient data of the whole cohort are provided in Tables 1 and 2 . A low-tidal-volume ventilation strategy was implemented during single lung ventilation. All patients received prophylactic first/second-generation cephalosporins until removal of chest tubes. However, if the patient was diagnosed with a postoperative infection, the antibiotic was adjusted to sulbactam, ampicillin, and ciprofloxacin. If there was no risk of aspiration, the patients were started on oral feedings in the sixth to eighth postoperative hour.
Variables and outcomes of interest
The variables comprised preoperative, intraoperative, and postoperative factors, extracted from medical records, ). Therefore, we used BMI of 24 kg/m 2 as the boundary for BMI grading. Preoperative renal insufficiency was defined as creatinine .50% the upper limit of the reference range, which is 1.3 and 1.1 mg/dL for men and women, respectively. 7 The amount of total intraoperative fluids was defined as the volumes of crystalloid, colloid, and blood products administered between initiation of anesthesia care and arrival in the postanesthesia care unit. 7 The colloid was hydroxyethyl starch. The net intraoperative total fluid was equal to the total intraoperative fluids minus intraoperative bleeding and urine output. Postoperative pathology of lung cancer included adenocarcinoma, squamous cell carcinoma, adenosquamous carcinoma, and small-cell lung cancer.
The PPCs included acute respiratory distress syndrome, reintubation, pneumonia, the need for bedside bronchoscopy, atelectasis, pulmonary embolism, prolonged air leak, and failure to expand during the period of postoperative hospitalization, as reported elsewhere. 8 The three criteria used to diagnose postoperative pneumonia were a new pulmonary infiltrate on chest X-ray, leukocytosis, and fever (ear temperature $38.0°C). 8, 9 Bedside bronchoscopy was used to clear lung secretions in the ward after the operation. Atelectasis was diagnosed by chest X-ray or computed tomography (CT), and pulmonary embolism was diagnosed 
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Yang et al by pulmonary artery CT angiography. A prolonged air leak was defined as leak .7 days. 8 Failure to expand was accepted as the inability of the remaining lung to completely fill the pleural cavity with or without air leak, which was diagnosed by chest X-ray. 8 The PLOS was defined as the number of hospitalized days after surgery. Hospital costs were the total hospital care costs. Among the 729 patients, 181 (24.8%) had PPCs and were classified into a PPCs group. The remaining 
Statistical analysis
Potential risk factors were detected using single-factor analysis. Continuous data were analyzed using one-way variance analysis. If the variance was not homogeneous, a nonparametric test (Kruskal-Wallis H-test for multiple independent samples) was used. Categorical variables were compared by the R×C chi-squared test or Fisher's exact test, as appropriate. The potential risk factors with P,0.05 were further assigned, imported into the binary logistic regression equation, and analyzed. Table S1 shows the assignment of variables in binary logistic regression analysis. P,0.05 was considered statistically significant. The OR and 95% CI were calculated. All analyses were performed using SPSS 25.0 (SPSS, Inc., Chicago, IL, USA).
7,10
Results
Patient selection and clinical outcomes
A total of 729 patients met our criteria for analysis ( Figure 1 ). The incidence of PPCs was 24.8% (n=181). The four most common PPCs were pneumonia (n=148, 20.3%), failure to expand (n=22, 3.0%), atelectasis (n=16, 2.2%), and prolonged air leak (n=16, 3.0%). No patient died during the period of hospitalization. The PLOS and total hospital care costs in the PPCs group were significantly higher than those in the no PPCs group (Table 3) .
Comparative univariate analysis of the potential risk factors of PPCs
Univariate analysis was performed to determine the potential risk factors for PPCs after minimally invasive anatomic resection for lung cancer. Compared to the no PPCs group, the PPCs group demonstrated significant differences in BMI grading (P=0.009), type of anatomical lung resection (P=0.007), surgical lobe (P=0.020), intraoperative bleeding (P=0.024), intraoperative bleeding grading (P=0.027), and length of anesthesia grading (P=0.040), while there were no discrepancies among the other variables (Tables 1 and 2 ).
Binary logistic regression analysis of the risk factors of PPCs
We included statistically significant factors in univariate analysis, namely, BMI grading, type of anatomical lung resection, surgical lobe, intraoperative bleeding grading, and length of anesthesia grading, in our binary logistic regression model, to evaluate the perioperative predictors of PPCs. 
Discussion
This study has shown a PPC frequency of 24.8% in lung cancer patients undergoing minimally invasive anatomic resection, which is still associated with significantly poor short-term outcomes, including increased PLOS and total hospital care costs (Table 3) . No patient died during the period of hospitalization. Furthermore, four independent risk factors for PPCs after minimally invasive anatomic resection for lung cancer were identified: BMI $24.0 kg/m 2 , single segmentectomy, bilobectomy or combined lobectomy and segmentectomy, and right lung lobe surgery (Table 4) .
The incidence of PPCs after lung resection varies. Agostini et al 11 reported frequencies of 7.4%, and Lugg et al 6 documented a prevalence of 13.0%, whereas Arslantas et al 8 noted that PPCs occurred in 54.7% patients after lung resection. This fluctuation is due to the differences in the definition of PPCs. In the current study, PPCs were defined similarly to Arslantas et al, 8 which included acute respiratory distress syndrome, reintubation, pneumonia, need for bedside bronchoscopy, atelectasis, pulmonary embolism, prolonged air leak, and failure to expand during the period of postoperative hospitalization. Our incidence of PPCs was 24.8%, which was compatible with the reported frequency. 1 In our series, the four most frequent complications were pneumonia (20.3%), failure to expand (3.0%), atelectasis (2.2%), and prolonged air leak (3.0%) ( Table 3) . No reintubation was identified in our series.
BMI is a well-known risk factor for PPCs. 1 Being underweight or overweight has been shown to increase the risk of PPCs after lung resection. 12 Our data demonstrated that the risk of PPCs in patients with BMI $24.0 kg/m 2 was higher than in patients with BMI ,24.0 kg/m 2 (OR 1.514, 95% CI 1.057-2.167, P=0.024) ( Table 4) . Obese patients often have reduced lung volume, altered ventilation pattern, and comorbid conditions, which are risk factors for intraand postoperative complications. 13, 14 Being overweight is an important influencing factor on pre-and postoperative immune function. 15 Additionally, an elevated BMI in patients will lead to increased difficulty during surgery and prolonged operative times. 16 The prevalence of overweight and obesity is showing an upward trend. 17 Thoracic surgeons will encounter more overweight and obese lung cancer patients in the future. Therefore, it was important to find whether BMI $24.0 kg/m 2 negatively impacts on outcomes after minimally invasive anatomic lung resection. Although a 
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Lobectomy has been the standard procedure for surgical treatment of non-small-cell lung cancer. In recent years, there has been growing evidence suggesting that segmentectomy can yield results equivalent to lobectomy in patients with early non-small-cell lung cancer. 18 However, few reports have investigated postoperative complications exclusively in patients with lung cancer undergoing lobectomy or segmentectomy. In the present investigation, compared with single lobectomy, single segmentectomy and bilobectomy or combined lobectomy and segmentectomy were associated with an increased risk of PPCs (Table 4) . Why is segmentectomy more prone to PPCs? Patients after segmentectomy had worse mean FEV1 than after lobectomy. 19 When performing segmentectomy, surgeons have to divide the intersegmental plane using staplers or electrocautery, which may cause postoperative air leak and development of PPCs. 18 Moreover, frequent clamping and pulling of the healthy lung tissue during segmentectomy would lead to postoperative pulmonary edema and development of PPCs. 20 Unsurprisingly, bilobectomy or combined lobectomy and segmentectomy were associated with the development of PPCs because they produce greater trauma and more lung surface wound than single lobectomy.
Little information about the effects of lung surgery, performed on different lung lobes, on postoperative outcomes has been published to date. Our multivariate analysis revealed that patients undergoing right lung lobe surgery had an increased risk of PPCs (Table 4 ). The association is possibly related to the difference in lung volume between the left and right lung (ratio of right and left lung volume, 1.22±0.14), 21 so the right lung lobe surgery has a greater impact on lung function, resulting in greater trauma and a higher risk of PPCs. In addition, because most of the bilobectomy or combined lobectomy and segmentectomy surgeries involved the right lung (15/17) , the surgery of the right lung lobe was associated with an increasing risk of PPCs.
Limitations
There were several limitations to this study. First, it was a single-center retrospective analysis, which may restrict the wide usage of our indications in clinics. A prospective multi-center study would be necessary to validate the risk factors of PPCs identified in our research and to define the best predictors of PPCs more rigorously. Second, numerous perioperative variables can lead to PPCs, but it is unlikely that all of these possible variables will be included in the study. Third, we only followed up our patients during their hospitalization. Hence, longitudinal studies are needed to evaluate the long-term clinical impacts of PPCs.
Conclusion
We identified several perioperative risk factors of PPCs following minimally invasive anatomic resection for lung cancer, including BMI $24.0 kg/m 2 , single segmentectomy, bilobectomy or combined lobectomy and segmentectomy, and right lung lobe surgery. These results should be helpful for risk stratification, patient counseling, and perioperative care of lung cancer patients. Further studies are necessary to validate these findings and create a clinical scoring system to predict PPCs.
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